Open consultation: Branded medicines: statutory scheme

Department Of Health

January 21
11:16 2020

This consultation seeks views on proposed changes to the statutory scheme to control the costs of branded medicines.

The consultation focuses specifically on proposed amendments to the payment percentages that are currently set out in the legislation for the statutory scheme.

We propose adjusting the payment percentages for 2020 and 2021 to help ensure allowed growth in statutory scheme sales of branded medicines to the NHS is limited to the current rate of 1.1% per year.


Impact assessment: statutory scheme to control costs of branded health service medicines

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email tell us what format you need. It will help us if you say what assistive technology you use.

Ways to respond

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: